MAIA Biotechnology, Inc.
General ticker "MAIA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $50.3M (TTM average)
MAIA Biotechnology, Inc. follows the US Stock Market performance with the rate: 1.8%.
Estimated limits based on current volatility of 2.6%: low 1.43$, high 1.51$
Factors to consider:
- Total employees count: 13 (0.0%) as of 2025
- Top business risk factors: Net losses continue, Financing unavailable, Dilution risk, Limited operating history, THIO failure
- Price in estimated range
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.78$, 2.39$]
- 2026-12-31 to 2027-12-31 estimated range: [0.77$, 2.33$]
Financial Metrics affecting the MAIA estimates:
- Positive: with PPE of -2.0 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: 19.19 < Shareholder equity ratio, % of 24.48 <= 42.57
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Investing cash flow per share per price, % of 0 > -0.60
- Negative: negative Net income
Short-term MAIA quotes
Long-term MAIA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $20.18MM | $16.96MM | $24.27MM |
| Operating Income | $-20.18MM | $-16.96MM | $-24.27MM |
| Non-Operating Income | $0.06MM | $-6.46MM | $1.87MM |
| Interest Expense | $0.01MM | $0.00MM | $0.00MM |
| R&D Expense | $11.11MM | $10.01MM | $14.55MM |
| Income(Loss) | $-20.13MM | $-23.41MM | $-22.40MM |
| Net Income(Loss)* | $-19.77MM | $-23.25MM | $-22.40MM |
| Stockholders Equity | $0.48MM | $3.63MM | $2.38MM |
| Assets | $7.57MM | $10.16MM | $9.70MM |
| Operating Cash Flow | $-13.07MM | $-15.70MM | $-18.84MM |
| Investing Cash Flow | $-0.00MM | $-0.02MM | $0.00MM |
| Financing Cash Flow | $9.27MM | $18.18MM | $17.91MM |
| Earnings Per Share** | $-1.49 | $-1.05 | $-0.70 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.